Sobos semaglutide page explains that semaglutide acts as a GLP-1 agonist and may help reduce appetite, slow gastric emptying, promote fullness, and support weight loss more effectively than diet and exercise alone for some patients
In This Article [show] The Peptide Landscape: BPC-157, TB-500, and GHK-Cu Therapeutic peptides are short chains of amino acids that affect specific biological pathways involved in tissue repair, inflammation, and regeneration
Patients who have a history of stimulant use but are no longer on ADHD medication frequently require higher doses to achieve meaningful appetite suppression, and even then outcomes can be more limited
The Phase 2 retatrutide trial (PMID 37366315) reported -24.2% body weight change at the 12 mg weekly dose across 48 weeks
Methionine, inositol, choline, and L-carnitine
One intriguing aspect of GLP-1s' potential impact on skin health is their ability to slow down the aging process